You are here

Novartis

What could help biotech close out 2019 stronger? Analysts pick 3 events to watch

Biopharma Dive

Sat, 09/7/19 - 06:38 pm

KRAS inhibitors

PTC Therapeutics

Novartis’ lung cancer drug edges closer to market after FDA grants fast review

Pharmaforum

Fri, 09/6/19 - 12:27 pm

breakthrough therapy

non-small cell lung cancer

Benevolent AI and Novartis sign AI R&D deal

Pharmaforum

Fri, 09/6/19 - 10:14 am

artificial intelligence

With third pharma deal, IFM's unorthodox approach paying off

Biopharma Dive

Thu, 09/5/19 - 08:22 pm

IFM Therapeutics

Bristol-Myers Squibb

Potential buyers size up Novartis site as layoffs loom for 400 workers

Fierce Pharma

Wed, 09/4/19 - 11:24 pm

drug manufacturing

UK cost watchdog recommends Novartis' blindness therapy Luxturna

Yahoo/Reuters

Wed, 09/4/19 - 10:18 am

Spark Therapeutics

Novartis strikes marketing deal for Polpharma’s potential Tysabri biosimilar

Pharmaforum

Tue, 09/3/19 - 10:30 am

Novartis’ ofatumumab meets primary endpoints in two phase 3 RMS trials

Pharmaceutical Business Review

Mon, 09/2/19 - 12:24 pm

clinical trials

relapsing multiple sclerosis

ESC: Novartis looks for the bright side in flopped Entresto heart failure study

Fierce Pharma

Mon, 09/2/19 - 12:19 pm

clinical trials

European Society of Cardiology

Novartis takes aim at Roche's star MS drug

Reuters

Fri, 08/30/19 - 10:08 am

multiple sclerosis

Does competition equal lower prices? MS drugs defied cost logic as challengers swarmed in

Fierce Pharma

Thu, 08/29/19 - 08:18 pm

multiple sclerosis

Teva Pharmaceutical

Novartis earlier acknowledged Zolgensma data errors to FDA but blamed them on poor reporting

Fierce Pharma

Tue, 08/27/19 - 12:06 pm

FDA asks why Novartis took two months to launch formal internal probe, after AveXis flagged data manipulation

Endpoints

Fri, 08/23/19 - 10:17 am

Amgen, Allergan biosimilar of Roche's blockbuster Rituxan clears another US pivotal study

Endpoints

Thu, 08/22/19 - 11:54 am

FDA on Novartis data manipulation controversy: ‘We happened to be lucky’

Stat

Wed, 08/21/19 - 10:38 am

AveXis scientific founder fires back at Novartis CEO Vas Narasimhan, 'categorically denies any wrongdoing'

Endpoints

Mon, 08/19/19 - 11:36 pm

Novartis CEO Says FDA Process Could Have Been Handled Better

Bloomberg

Mon, 08/19/19 - 10:33 am

What happened a year ago this week in biopharma? August 12-18, 2018

Mon, 08/19/19 - 11:04 am

Vertex Pharmaceuticals

cystic fibrosis

Bristol-Myers Squibb

Novartis to answer U.S. Senate demand for data manipulation details

Yahoo/Reuters

Mon, 08/19/19 - 09:55 am

What happened a year ago this week in biopharma? August 12-18, 2018

CP WIre

Sun, 08/18/19 - 04:30 pm

Vertex Pharmaceuticals

cystic fibrosis

Bristol-Myers Squibb

Pages